The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species

Overview of attention for article published in Frontiers in Pharmacology, July 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 13,053 followers.

Brensocatib represents a new MOA (for me anyway) - preventing neutrophil maturation/activity - https://t.co/VEoOw705ZE

28 May 2024

Reply Repost Favourite

PubMed LATEST: The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species https://t.co/p8pW3G3eEq

04 Aug 2023

Reply Repost Favourite

RT @FrontPharmacol: New Research: The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3…

19 Jul 2023

Reply Repost Favourite

New Research: The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species #pharmacology https://t.co/hGgjWMpBHz

19 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.